Comparison 15. Nicotine EC + varenicline vs. varenicline.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
15.1 Adverse events at 12 weeks | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
15.2 Serious adverse events at 12 weeks | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |